Laurion Capital Management LP Spectrum Pharmaceuticals Inc Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.4 $42,433 - $84,866	60,619 New	60,619 $47,000
Q3 2019 Nov 13, 2019	SELL	$7.03 - $9.7 $532,227 - $734,367	-75,708 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$7.36 - $11.26 $557,210 - $852,472	75,708 New	75,708 $652,000
Q3 2018 Nov 13, 2018	SELL	$16.52 - $24.82 $344,888 - $518,167	-20,877 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$14.31 - $21.75 $298,749 - $454,074	20,877 New	20,877 $438,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.